Time Restricted Eating for Patients with Sleep Apnea
Official title: The Time Restricted Eating in Sleep Apnea Study
Run by University of California, San Diego · NCT06047496 · Data updated 2026-11-12
This study is testing if a new eating schedule can help people with sleep apnea improve their metabolism and overall health.
Quick facts
| Phase | Early Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of California, San Diego Academic / other |
| Locations | 1 site (La Jolla, California) |
| Status | Recruiting |
| Started | January 5, 2024 |
| Main results expected | July 2027 |
| Study ends | December 2028 |
| Registry record updated | January 16, 2024 |
| Trial ID | NCT06047496 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-70 with untreated moderate to severe obstructive sleep apnea and a baseline eating period of at least 12 hours per day.
✕Probably not a fit
Patients with diabetes requiring insulin or sulfonylureas, or those with significant sleepiness due to OSA may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of time restricted eating (TRE) on metabolic dysfunction in patients with obstructive sleep apnea (OSA). Participants will undergo a baseline period where they will log their dietary intake using a mobile app and wear a continuous glucose monitor. Following this, they will be randomized to implement TRE to assess its impact on glucose and lipid metabolism. The study aims to provide insights into alternative therapies for managing metabolic issues associated with OSA.
Why it matters
Potential benefit: If successful, this approach could improve metabolic health and overall quality of life for patients with obstructive sleep apnea.
How similar studies have gone: While some human studies have shown improvements in metabolic dysfunction with time restricted eating, this specific application in OSA has not been previously examined.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Provision of signed and dated informed consent form; * Stated willingness to comply with all study procedures and availability for the duration of the study; * Be of appropriate age (18-70); * Own a smartphone (Apple iOS or Android OS); * Have a baseline eating period ≥12 hours/day and sufficient logging on the myCircadianClock app; * If participants are on cardiovascular medications (HMG CoA reductase inhibitors (statins), other lipid-modifying drugs, anti-hypertensives) no dose adjustments will be allowed during the study period; * Have untreated moderate to severe obstructive sleep apnea (OSA, apnea-hypopnea index ≥15 events/hr); and * Agree to adhere to Lifestyle Considerations (see section 5.3) throughout study duration\] Exclusion Criteria: * Participants with type 1 or type 2 diabetes mellitus who are taking insulin or sulfonylureas, or any participant with a history of hypoglycemia unawareness * OSA with evidence of significant sleepiness, as defined by either a) Epworth Sleepiness Score ≥15, or b) motor vehicle accident due to excessive sleepiness within the past year * BMI \>40 kg/m2 * Uncontrolled hypertension * Active tobacco or illicit drug use * Pregnant or breastfeeding women * Currently enrolled in a weight-loss or weight-management program * Currently on a special or prescribed diet for other reasons (e.g., Celiac disease) * Currently taking any medication that is meant for weight loss, or has known effect on appetite suppression * History of eating disorder(s) * History of surgical intervention for weight management * Chronic kidney disease * Treatment for active inflammatory and/or rheumatologic disease and cancer * Unrevascularized cardiovascular disease * Liver cirrhosis and/or significant alterations in liver function * History of (a) thyroid disease requiring dose titration of thyroid replacement medication(s) within the past 3 months (i.e., hypothyroidism on a stable dose of thyroid replacement therapy is not an exclusion) * Shift workers with variable (e.g., occasionally nocturnal) hours * Traveling outside the US * History of HIV/AIDS * Uncontrolled psychiatric disorder * Other safety concern based on MD judgement
Where it's running
-
University of California San Diego (ACTRI)
La Jolla, California, United States Recruiting
Study contacts
- Principal investigator: Omar Mesarwi, MD — University of California, San Diego
- Study coordinator: Pamela DeYoung, RPSGT
- Email: pdeyoung@health.ucsd.edu
- Phone: (858) 246-2154
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.